Valo Therapeutics Oy
🇫🇮Finland
- Country
- 🇫🇮Finland
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.valotx.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Phase 1
Recruiting
- Conditions
- Melanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung CancerSynovial SarcomaMyxoid LiposarcomaColorectal CancerOsteosarcomaSarcoma
- Interventions
- First Posted Date
- 2022-08-08
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Valo Therapeutics Oy
- Target Recruit Count
- 15
- Registration Number
- NCT05492682
- Locations
- 🇩🇪
Krankenhaus Nordwest, Frankfurt, Germany
🇩🇪National Center for Tumor Diseases, Heidelberg, Germany
🇩🇪Universitätsklinikum Tübingen, Tübingen, Germany
News
No news found